These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33674591)

  • 1. Deciphering the state of immune silence in fatal COVID-19 patients.
    Bost P; De Sanctis F; Canè S; Ugel S; Donadello K; Castellucci M; Eyal D; Fiore A; Anselmi C; Barouni RM; Trovato R; Caligola S; Lamolinara A; Iezzi M; Facciotti F; Mazzariol A; Gibellini D; De Nardo P; Tacconelli E; Gottin L; Polati E; Schwikowski B; Amit I; Bronte V
    Nat Commun; 2021 Mar; 12(1):1428. PubMed ID: 33674591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.
    Szabo PA; Dogra P; Gray JI; Wells SB; Connors TJ; Weisberg SP; Krupska I; Matsumoto R; Poon MML; Idzikowski E; Morris SE; Pasin C; Yates AJ; Ku A; Chait M; Davis-Porada J; Guo XV; Zhou J; Steinle M; Mackay S; Saqi A; Baldwin MR; Sims PA; Farber DL
    Immunity; 2021 Apr; 54(4):797-814.e6. PubMed ID: 33765436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
    Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
    Ma Y; Qiu F; Deng C; Li J; Huang Y; Wu Z; Zhou Y; Zhang Y; Xiong Y; Yao Y; Zhong Y; Qu J; Su J
    Genome Med; 2022 Feb; 14(1):16. PubMed ID: 35172892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
    Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
    Front Immunol; 2021; 12():627548. PubMed ID: 33777012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.
    Tomić S; Đokić J; Stevanović D; Ilić N; Gruden-Movsesijan A; Dinić M; Radojević D; Bekić M; Mitrović N; Tomašević R; Mikić D; Stojanović D; Čolić M
    Front Immunol; 2021; 12():614599. PubMed ID: 33692788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
    Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
    J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions.
    Siemińska I; Węglarczyk K; Surmiak M; Kurowska-Baran D; Sanak M; Siedlar M; Baran J
    Front Immunol; 2021; 12():748097. PubMed ID: 34659245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19.
    Zenarruzabeitia O; Astarloa-Pando G; Terrén I; Orrantia A; Pérez-Garay R; Seijas-Betolaza I; Nieto-Arana J; Imaz-Ayo N; Pérez-Fernández S; Arana-Arri E; Borrego F
    Front Immunol; 2021; 12():655934. PubMed ID: 33777054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
    Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
    Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique immunological profile in patients with COVID-19.
    Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
    Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response.
    Loretelli C; Abdelsalam A; D'Addio F; Ben Nasr M; Assi E; Usuelli V; Maestroni A; Seelam AJ; Ippolito E; Di Maggio S; Loreggian L; Radovanovic D; Vanetti C; Yang J; El Essawy B; Rossi A; Pastore I; Montefusco L; Lunati ME; Bolla AM; Biasin M; Antinori S; Santus P; Riva A; Zuccotti GV; Galli M; Rusconi S; Fiorina P
    JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34784300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Immune Profiling Reveals CD56
    Dutt TS; LaVergne SM; Webb TL; Baxter BA; Stromberg S; McFann K; Berry K; Tipton M; Alnachoukati O; Zier L; Ebel G; Dunn J; Henao-Tamayo M; Ryan EP
    J Immunol; 2022 Feb; 208(3):685-696. PubMed ID: 34987111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
    Front Immunol; 2020; 11():596553. PubMed ID: 33324414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
    Veglia F; Sanseviero E; Gabrilovich DI
    Nat Rev Immunol; 2021 Aug; 21(8):485-498. PubMed ID: 33526920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in immune responses that underlie COVID-19 disease outcomes.
    Takahashi T; Ellingson MK; Wong P; Israelow B; Lucas C; Klein J; Silva J; Mao T; Oh JE; Tokuyama M; Lu P; Venkataraman A; Park A; Liu F; Meir A; Sun J; Wang EY; Casanovas-Massana A; Wyllie AL; Vogels CBF; Earnest R; Lapidus S; Ott IM; Moore AJ; ; Shaw A; Fournier JB; Odio CD; Farhadian S; Dela Cruz C; Grubaugh ND; Schulz WL; Ring AM; Ko AI; Omer SB; Iwasaki A
    Nature; 2020 Dec; 588(7837):315-320. PubMed ID: 32846427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome?
    Sami R; Fathi F; Eskandari N; Ahmadi M; ArefNezhad R; Motedayyen H
    Cytokine; 2021 Apr; 140():155439. PubMed ID: 33524886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent High Percentage of HLA-DR
    Du J; Wei L; Li G; Hua M; Sun Y; Wang D; Han K; Yan Y; Song C; Song R; Zhang H; Han J; Liu J; Kong Y
    Front Immunol; 2021; 12():735125. PubMed ID: 34567001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.